Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Resistance of neonatal porcine Sertoli cells to human xenoantibody and complement-mediated lysis is associated with low expression of alpha-Gal and high production of clusterin and CD59.

Yin Z, Wang L, Xiang Y, Ruan Y, Li J, Wang X, Ichim TE, Chen S, Chen G.

Xenotransplantation. 2010 May-Jun;17(3):215-23. doi: 10.1111/j.1399-3089.2010.00581.x.

PMID:
20636542
2.
3.

Neonatal porcine Sertoli cells inhibit human natural antibody-mediated lysis.

Dufour JM, Hamilton M, Rajotte RV, Korbutt GS.

Biol Reprod. 2005 May;72(5):1224-31. Epub 2005 Jan 19.

4.

Mechanism of humoral and cellular immune modulation provided by porcine sertoli cells.

Lee HM, Oh BC, Lim DP, Lee DS, Lim HG, Park CS, Lee JR.

J Korean Med Sci. 2008 Jun;23(3):514-20. doi: 10.3346/jkms.2008.23.3.514.

5.

Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.

Saethre M, Baumann BC, Fung M, Seebach JD, Mollnes TE.

Transplantation. 2007 Jul 27;84(2):244-50.

PMID:
17667817
6.

Expression of Gal alpha(1,3)gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis.

Rayat GR, Rajotte RV, Elliott JF, Korbutt GS.

Diabetes. 1998 Sep;47(9):1406-11.

PMID:
9726228
7.

Protection of MLV vector particles from human complement.

Breun S, Salmons B, Günzburg WH, Baumann JG.

Biochem Biophys Res Commun. 1999 Oct 14;264(1):1-5.

PMID:
10527830
8.
9.

Oxidant stress increases susceptibility of porcine endothelial cells to injury by xenoreactive antibody and complement.

Magee JC, Platt JL, Oldham KT, Guice KS.

Transplant Proc. 1994 Jun;26(3):1170. No abstract available.

PMID:
8029874
10.

C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.

Miyagawa S, Mikata S, Shirakura R, Matsuda H, Nagasawa S, Terados A, Hatanaka M, Matsumoto M, Seya T.

Scand J Immunol. 1996 Apr;43(4):361-6.

PMID:
8668913
11.

Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.

Huang J, Gou D, Zhen C, Jiang D, Mao X, Li W, Chen S, Cai C.

FEMS Immunol Med Microbiol. 2001 Oct;31(3):203-9.

12.

Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.

Kennedy SP, Rollins SA, Burton WV, Sims PJ, Bothwell AL, Squinto SP, Zavoico GB.

Transplantation. 1994 May 27;57(10):1494-501.

PMID:
7515200
13.

Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.

Bennet W, Björkland A, Sundberg B, Brandhorst D, Brendel MD, Richards A, White DJ, Nilsson B, Groth CG, Korsgren O.

Transplantation. 2001 Jul 27;72(2):312-9.

PMID:
11477359
14.

Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.

Baumann BC, Stussi G, Huggel K, Rieben R, Seebach JD.

Transplantation. 2007 Jan 27;83(2):193-201.

PMID:
17264816
15.

Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.

Clayton A, Harris CL, Court J, Mason MD, Morgan BP.

Eur J Immunol. 2003 Feb;33(2):522-31.

16.

Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation.

Zhu M, Zhang W, Liu F, Wang L, Liu B, Chen D, Zhu XH, Zhang WJ, Ichim TE, Chen ZS, Zhou P, Chen S, Chen G.

Transpl Immunol. 2008 Jul;19(3-4):202-8. doi: 10.1016/j.trim.2008.06.002. Epub 2008 Jul 1.

PMID:
18598766
17.

Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis.

Loveland BE, Johnstone RW, Russell SM, Thorley BR, McKenzie IF.

Transpl Immunol. 1993;1(2):101-8.

PMID:
8081768
18.

Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters.

Lindeborg E, Kumagai-Braesch M, Tibell A, Möller E.

Xenotransplantation. 2001 Nov;8(4):273-83.

PMID:
11737853
20.

Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.

Díaz-Román TM, Mañez R, López-Pelaez E, Centeno A, Moscoso I, Pértegaz S, Doménech N.

Transpl Immunol. 2006 Aug;16(2):125-30. Epub 2006 Apr 17.

PMID:
16860716
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk